Trial Profile
Cost-effectiveness of Different Antiretroviral Treatment in Patients HIV Naive. Randomized Clinical, Not Masked, Trial Comparing DRVr3TC, ABC3TC (Kivexa) RPV, or EVG COBI FTC TDF (Stribild) for 48 Weeks
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat (Primary) ; Darunavir; Lamivudine; Lamivudine/abacavir; Rilpivirine; Ritonavir
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- 04 Aug 2017 This trial has been completed in Spain, according to European Clinical Trials Database.
- 29 Jun 2016 Status changed from not yet recruiting to recruiting.
- 17 Jun 2015 New trial record